CIK 0001860742
- Large accelerated filer
Bausch & Lomb Corp
Sign in to watch- Ticker
- BLCO
- Exchange
- NYSE
- Industry
- Ophthalmic Goods
- FY end
- Dec 31
- Entity type
- Operating
- Phone
- +1 908-541-5456
- Business address
- 520 APPLEWOOD CRESCENT, VAUGHAN, Ontario, Canada, L4K 4B4
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $2,294,067
- in 1 filing
Net −$2,294,067. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2026-08-05 | Hashad Yehia EVP of R&D and CMO | Grant or award | +20,973 | 187,350 | ||
| 2026-05-05 | Hashad Yehia EVP of R&D and CMO | Shares withheld for taxes | −13,664 | $16.00 | $219K | 166,377 |
| 2026-02-27 | Hashad Yehia EVP of R&D and CMO | Shares withheld for taxes | −5,075 | $18.30 | $93K | 191,662 |
| 2026-02-27 | Hashad Yehia EVP of R&D and CMO | Shares withheld for taxes | −11,621 | $18.30 | $213K | 180,041 |
| 2026-02-26 | Hashad Yehia EVP of R&D and CMO | Shares withheld for taxes | −2,169 | $18.49 | $40K | 196,737 |
| 2026-02-25 | Hashad Yehia EVP of R&D and CMO | Grant or award | +35,046 | 198,906 | ||
| 2026-02-18 | Hashad Yehia EVP of R&D and CMO | Grant or award | +29,406 | 163,860 | ||
| 2025-08-05 | Hashad Yehia EVP of R&D and CMO | Grant or award | +17,715 | 134,454 | ||
| 2025-07-25 | Hashad Yehia EVP of R&D and CMO | Shares withheld for taxes | −2,841 | $14.32 | $41K | 116,739 |
| 2025-02-26 | Hashad Yehia EVP of R&D and CMO | Grant or award | +25,225 | 119,580 | ||
| 2025-02-26 | Hashad Yehia EVP of R&D and CMO | Grant or award · Non-Qualified Stock Options (right to purchase) | +60,085 | 60,085 | ||
| 2024-12-23 | Hashad Yehia EVP of R&D and CMO | Shares withheld for taxes | −2,324 | $17.83 | $41K | 97,106 |
| 2024-12-23 | Hashad Yehia EVP of R&D and CMO | Shares withheld for taxes | −2,751 | $17.83 | $49K | 94,355 |
| 2024-07-25 | Hashad Yehia EVP of R&D and CMO | Shares withheld for taxes | −2,841 | $15.53 | $44K | 99,430 |
| 2024-03-01 | Hashad Yehia EVP of R&D and CMO | Shares withheld for taxes | −2,143 | $16.47 | $35K | 102,271 |
| 2024-02-28 | Hashad Yehia EVP of R&D and CMO | Grant or award | +20,973 | 104,414 | ||
| 2024-02-28 | Hashad Yehia EVP of R&D and CMO | Grant or award · Non-Qualified Stock Options (right to purchase) | +63,516 | 63,516 | ||
| 2023-07-25 | Hashad Yehia EVP of R&D and CMO | Shares withheld for taxes | −3,996 | $19.82 | $79K | 83,441 |
| 2023-03-01 | Hashad Yehia EVP, R&D and CMO | Grant or award | +17,715 | 87,437 | ||
| 2023-03-01 | Hashad Yehia EVP, R&D and CMO | Grant or award · Non-Qualified Stock Options (right to purchase) | +56,715 | 56,715 |
Page 1 of 2 · 23 trades